{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T04:16:55Z","timestamp":1781842615678,"version":"3.54.5"},"reference-count":32,"publisher":"Japan Atherosclerosis Society","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT","J Atheroscler Thromb"],"published-print":{"date-parts":[[2022,6,1]]},"DOI":"10.5551\/jat.63222","type":"journal-article","created":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T22:10:42Z","timestamp":1634854242000},"page":"953-969","source":"Crossref","is-referenced-by-count":8,"title":["Prospective Registry Study of Primary Dyslipidemia (PROLIPID): Rationale and Study Design"],"prefix":"10.5551","volume":"29","author":[{"given":"Hayato","family":"Tada","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Kanazawa University Graduate School of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Kurashina","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Internal Medicine, School of Medicine, Jichi Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatsune","family":"Ogura","sequence":"additional","affiliation":[{"name":"Department of General Medical Science, Chiba University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misa","family":"Takegami","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine and Epidemiology, National Cerebral and Cardiovascular Center Research Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Miyamoto","sequence":"additional","affiliation":[{"name":"Department of Preventive Cardiology, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidenori","family":"Arai","sequence":"additional","affiliation":[{"name":"National Center for Geriatrics and Gerontology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariko","family":"Harada-Shiba","sequence":"additional","affiliation":[{"name":"Department of Molecular Pathogenesis, National Cerebral and Cardiovascular Center Research Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Ishibashi","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Internal Medicine, School of Medicine, Jichi Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Mabuchi H, Nohara A, Noguchi T, Kobayashi J, Kawashiri MA, Tada H, Nakanishi C, Mori M, Yamagishi M, Inazu A, Koizumi J; Hokuriku FH Study Group. Molecular genetic epidemiology of homozygous familial hypercholesterolemia in the Hokuriku district of Japan. Atherosclerosis, 2011; 214: 404-407","DOI":"10.1016\/j.atherosclerosis.2010.11.005"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Sekijima Y, Koyama S, Yoshinaga T, Koinuma M, Inaba Y. Nationwide survey on cerebrotendinous xanthomatosis in Japan. J Hum Genet, 2018; 63: 271-280","DOI":"10.1038\/s10038-017-0389-4"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Hu P, Dharmayat KI, Stevens CAT, Sharabiani MTA, Jones RS, Watts GF, Genest J, Ray KK, Vallejo-Vaz AJ. Prevalence of familial hypercholesterolemia among the general population and patients with atherosclerotic cardiovascular disease: a systematic review and meta-analysis. Circulation, 2020; 141: 1742-1759","DOI":"10.1161\/CIRCULATIONAHA.119.044795"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Beheshti SO, Madsen CM, Varbo A, Nordestgaard BG. Worldwide Prevalence of Familial Hypercholesterolemia: Meta-Analyses of 11 Million Subjects. J Am Coll Cardiol, 2020; 75: 2553-2566","DOI":"10.1016\/j.jacc.2020.03.057"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Mabuchi H. Half a century tales of familial hypercholesterolemia (FH) in Japan. J Atheroscler Thromb, 2017; 24: 189-207","DOI":"10.5551\/jat.RV16008"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Luirink IK, Wiegman A, Kusters DM, Hof MH, Groothoff JW, de Groot E, Kastelein JJP, Hutten BA. 20-Year Follow-up of Statins in Children with Familial Hypercholesterolemia. N Engl J Med, 2019; 381: 1547-1556","DOI":"10.1056\/NEJMoa1816454"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Tada H, Okada H, Nomura A, Nohara A, Yamagishi M, Takamura M, Kawashiri MA. Prognostic impact of cascade screening for familial hypercholesterolemia on cardiovascular events. J Clin Lipidol, 2021; 15: 358-365","DOI":"10.1016\/j.jacl.2020.12.012"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Yamamura T. Apolipoprotein E and Atherosclerosis. Doumyakukouka (Japanese), 1998; 25: 415-420","DOI":"10.5551\/jat1973.25.11-12_415"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Hopkins PN, Brinton EA, Nanjee MN. Hyperlipoproteinemia type 3: the forgotten phenotype. Curr Atheroscler Rep, 2014; 16: 440","DOI":"10.1007\/s11883-014-0440-2"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Harada-Shiba M, Arai H, Ishigaki Y, Ishibashi S, Okamura T, Ogura M, Dobashi K, Nohara A, Bujo H, Miyauchi K, Yamashita S, Yokote K and Working Group by Japan Atherosclerosis Society for Making Guidance of Familial H. Guidelines for diagnosis and treatment of familial hypercholesterolemia 2017. J Atheroscler Thromb, 2018; 25: 751-770","DOI":"10.5551\/jat.CR003"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Nohara A, Tada H, Ogura M, Okazaki S, Ono K, Shimano H, Daida H, Dobashi K, Hayashi T, Hori M, Matsuki K, Minamino T, Yokoyama S, Harada-Shiba M; Committee on Primary Dyslipidemia under the Research Program on Rare and Intractable Disease of the Ministry of Health, Labour and Welfare of Japan. Homozygous familial hypercholesterolemia. J Atheroscler Thromb, 2021; 28: 665-678","DOI":"10.5551\/jat.RV17050"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Luirink IK, Wiegman A, Kusters DM, Hof MH, Groothoff JW, de Groot E, Kastelein JJP, Hutten BA. 20-year follow-up of statins in children with familial hypercholesterolemia. N Engl J Med, 2019; 381: 1547-1556","DOI":"10.1056\/NEJMoa1816454"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Tada H, Okada H, Nomura A, Nohara A, Yamagishi M, Takamura M, Kawashiri MA. Prognostic impact of cascade screening for familial hypercholesterolemia on cardiovascular events. J Clin Lipidol, 2021 in press","DOI":"10.1093\/ehjci\/ehaa946.2983"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Tada H, Nohara A, Inazu A, Sakuma N, Mabuchi H, Kawashiri MA. Sitosterolemia, hypercholesterolemia, and coronary artery disease. J Atheroscler Thromb, 2018; 25: 783-789","DOI":"10.5551\/jat.RV17024"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Tada H, Nomura A, Ogura M, Ikewaki K, Ishigaki Y, Inagaki K, Tsukamoto K, Dobashi K, Nakamura K, Hori M, Matsuki K, Yamashita S, Yokoyama S, Kawashiri MA, Harada-Shiba M; Committee on Primary Dyslipidemia under the Research Program on Rare and Intractable Desease of the Ministry of Health, Labour and Welfare of Japan. Diagnosis and management of sitosterolemia 2021. J Atheroscler Thromb, 2021; 28: 791-801","DOI":"10.5551\/jat.RV17052"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Koyama S, Sekijima Y, Ogura M, Hori M, Matsuki K, Miida T, Harada-Shiba M, Committee on Primary Dyslipidemia under the Research Program on Rare and Intractable Disease of the Ministry of Health, Labor and Welfare of Japan. Cerebrotendinous xanthomatosis: molecular pathogenesis, clinical spectrum, diagnosis, and disease-modifying treatments. J Atheroscler Thromb, 2021; 28: 905-925","DOI":"10.5551\/jat.RV17055"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Takahashi M, Okazaki H, Ohashi K, Ogura M, Ishibashi S, Okazaki S, Hirayama S, Hori M, Matsuki K, Yokoyama S, Harada-Shiba M, Committee on Primary Dyslipidemia under the Research Program on R, Intractable Disease of the Ministry of Health, Labor and Welfare of Japan. Current Diagnosis and Management of Abetalipoproteinemia. J Atheroscler Thromb, 2021; 28: 1009-1019","DOI":"10.5551\/jat.RV17056"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Okazaki H, Gotoda T, Ogura M, Ishibashi S, Inagaki K, Daida H, Hayashi T, Hori M, Masuda D, Matsuki K, Yokoyama S, Harada-Shiba M, Committee on Primary Dyslipidemia under the Research Program on Rare and Intractable Disease of the Ministry of Health, Labor and Welfare of Japan. Current diagnosis and management of primary chylomicronemia. J Atheroscler Thromb, 2021; 28: 883-904","DOI":"10.5551\/jat.RV17054"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Koseki M, Yamashita S, Ogura M, Ishigaki Y, Ono K, Tsukamoto K, Hori M, Matsuki K, Yokoyama S, Harada-Shiba M, Committee on Primary Dyslipidemia under the Research Program on R, Intractable Disease of the Ministry of Health, Labor and Welfare of Japan. Current diagnosis and management of Tangier disease. J Atheroscler Thromb, 2021; 28: 802-810","DOI":"10.5551\/jat.RV17053"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Kuroda M, Bujo H, Yokote K, Murano T, Yamaguchi T, Ogura M, Ikewaki K, Koseki M, Takeuchi Y, Nakatsuka A, Hori M, Matsuki K, Miida T, Yokoyama S, Wada J, Harada-Shiba M; Committee on Primary Dyslipidemia under the Research Program on Rare and Intractable Disease of the Ministry of Health, Labour and Welfare of Japan. Current status of familial LCAT deficiency in Japan. J Atheroscler Thromb, 2021; 28: 679-691","DOI":"10.5551\/jat.RV17051"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Moriyama K, Sasaki J, Takada Y, Matsunaga A, Fukui J, Albers JJ, Arakawa K. A cysteine-containing truncated apo A-I variant associated with HDL deficiency. Arterioscler Thromb Vasc Biol, 1996; 16: 1416-1423","DOI":"10.1161\/01.ATV.16.12.1416"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Huang W, Sasaki J, Matsunaga A, Nanimatsu H, Moriyama K, Han H, Kugi M, Koga T, Yamaguchi K, Arakawa K. A novel homozygous missense mutation in the apo A-I gene with apo A-I deficiency. Arterioscler Thromb Vasc Biol, 1998; 18: 389-396","DOI":"10.1161\/01.ATV.18.3.389"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Bujo H, Takahashi K, Saito Y, Maruyama T, Yamashita S, Matsuzawa Y, Ishibashi S, Shionoiri F, Yamada N, Kita T; Research Committeon Primary Hyperlipidemia of the Ministry of Health, Labour, and Welfare of Japan. Clinical features of familial hypercholesterolemia in Japan in a database from 1996-1998 by the research committee of the ministry of health, labour and welfare of Japan. J Atheroscler Thromb, 2004; 11: 146-151","DOI":"10.5551\/jat.11.146"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Maruyama T, Yamashita S, Matsuzawa Y, Bujo H, Takahashi K, Saito Y, Ishibashi S, Ohashi K, Shionoiri F, Gotoda T, Yamada N, Kita T; Research Committee on Primary Hyperlipidemia of the Ministry of Health and Welfare of Japan. Mutations in Japanese subjects with primary hyperlipidemia--results from the Research Committee of the Ministry of Health and Welfare of Japan since 1996--. J Atheroscler Thromb, 2004; 11: 131-145","DOI":"10.5551\/jat.11.131"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) P\u00e9rez de Isla L, Alonso R, Mata N, Fern\u00e1ndez-P\u00e9rez C, Mu\u00f1iz O, D\u00edaz-D\u00edaz JL, Saltijeral A, Fuentes-Jim\u00e9nez F, de Andr\u00e9s R, Zamb\u00f3n D, Piedecausa M, Cepeda JM, Mauri M, Galiana J, Brea \u00c1, Sanchez Mu\u00f1oz-Torrero JF, Padr\u00f3 T, Argueso R, Miramontes-Gonz\u00e1lez JP, Badim\u00f3n L, Santos RD, Watts GF, Mata P. Predicting cardiovascular events in familial hypercholesterolemia: The SAFEHEART Registry (Spanish Familial Hypercholesterolemia Cohort Study). Circulation, 2017; 135: 2133-2144","DOI":"10.1161\/CIRCULATIONAHA.116.024541"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Humphries SE, Cooper JA, Seed M, Capps N, Durrington PN, Jones B, McDowell IFW, Soran H, Neil HAW; Simon Broome Familial Hyperlipidaemia Register Group. Coronary heart disease mortality in treated familial hypercholesterolaemia: Update of the UK Simon Broome FH register. Atherosclerosis, 2018; 274: 41-46","DOI":"10.1016\/j.atherosclerosis.2018.04.040"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Yamashita S, Masuda D, Harada-Shiba M, Arai H, Bujo H, Ishibashi S, Daida H, Koga N, Oikawa S and Group FS. Effectiveness and safety of lipid-lowering drug treatments in Japanese patients with familial hypercholesterolemia: Familial Hypercholesterolemia Expert Forum (FAME) Study. J Atheroscler Thromb, 2022; 29: 608-638","DOI":"10.5551\/jat.62764"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Naito R, Daida H, Masuda D, Harada-Shiba M, Arai H, Bujo H, Ishibashi S, Koga N, Oikawa S, Yamashita S. Relation of Serum Lipoprotein(a) Levels to Lipoprotein and Apolipoprotein Profiles and Atherosclerotic Diseases in Japanese Patients with Heterozygous Familial Hypercholesterolemia: Familial Hypercholesterolemia Expert Forum (FAME) Study. J Atheroscler Thromb, 2021 in press. doi: http: \/\/doi.org\/10.5551\/jat.63019","DOI":"10.5551\/jat.63019"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Ogura M, Harada-Shiba M, Masuda D, Arai H, Bujo H, Ishibashi S, Daida H, Koga N, Oikawa S, Yamashita S; FAME Study Group. Factors Associated with Carotid Atherosclerosis and Achilles Tendon Thickness in Japanese Patients with Familial Hypercholesterolemia: A Subanalysis of the Familial Hypercholesterolemia Expert Forum (FAME) Study. J Atheroscler Thromb, 2022; 29: 906-922","DOI":"10.5551\/jat.62925"},{"key":"30","unstructured":"30) https: \/\/www.nanbyou.or.jp\/entry\/5354 (Last accessed at July 21, 2021)"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Tada H, Kawashiri MA, Nohara A, Inazu A, Mabuchi H, Yamagishi M. Impact of clinical signs and genetic diagnosis of familial hypercholesterolaemia on the prevalence of coronary artery disease in patients with severe hypercholesterolaemia. Eur Heart J, 2017; 38: 1573-1579","DOI":"10.1093\/eurheartj\/ehx004"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Tada H, Kawashiri MA, Nohara A, Sakata K, Inazu A, Mabuchi H, Yamagishi M, Hayashi K. Remnant-like particles and coronary artery disease in familial hypercholesterolemia. Clin Chim Acta, 2018; 482: 120-123","DOI":"10.1016\/j.cca.2018.04.007"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/29\/6\/29_63222\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,4]],"date-time":"2022-06-04T05:02:18Z","timestamp":1654318938000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/29\/6\/29_63222\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,1]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.63222","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,1]]},"article-number":"63222"}}